Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
polysaccharide
sulfated polysaccharide |
| gptkbp:abbreviation |
DS or DSS
|
| gptkbp:administeredBy |
intravenous route
|
| gptkbp:CASNumber |
9011-18-1
|
| gptkbp:charge |
anionic
|
| gptkbp:color |
white to off-white powder
|
| gptkbp:contains |
sulfate groups
|
| gptkbp:derivedFrom |
dextran
|
| gptkbp:hasMolecularWeightRange |
5,000 to 500,000 Da
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dextran sulfate
|
| gptkbp:sideEffect |
nephrotoxicity
coagulopathy |
| gptkbp:solubility |
water-soluble
|
| gptkbp:studiedBy |
induction of colitis in animal models
study of HIV inhibition |
| gptkbp:usedAs |
gptkb:anticoagulant
antiviral drug laboratory reagent |
| gptkbp:usedIn |
lipoprotein separation
plasma volume expansion |
| gptkbp:bfsParent |
gptkb:Dextran
|
| gptkbp:bfsLayer |
6
|